期刊文献+

SHIP1在急性髓细胞白血病患者中的表达及对人白血病细胞凋亡的影响研究 被引量:1

Expression of SHIP1 in the Patients with Acute Myeloid Leukemia and Its Influence on the Apoptosis of Human Leukemia Cells
原文传递
导出
摘要 目的:探讨含SH2结构域的肌醇1(SHIP1)在急性髓细胞白血病患者中的表达及对人白血病细胞凋亡的影响。方法:采用Western blot检测收集的急性髓细胞白血病患者骨髓中SHIP1的表达。人白血病细胞U937转染SHIP1过表达载体(pEGFP-SHIP1组)及对照空载体(pEGFP组),同时设置对照组,对照组细胞不转染载体,其他步骤同pEGFP-SHIP1组和pEGFP组。流式细胞仪检测48 h的细胞凋亡情况,Western blot检测48 h细胞中SHIP1、Bcl-2、Bax、Akt、p-Akt的表达。结果:急性髓细胞白血病患者骨髓中SHIP1表达明显低于正常人(P<0.05)。pEGFP-SHIP1组细胞中SHIP1、Bax表达和凋亡率均明显高于pEGFP组及对照组(P<0.01),Bcl-2、p-Akt表达均明显低于对照组(P<0.01)。结论:SHIP1在急性髓细胞白血病患者骨髓中表达下调,其可能通过Akt信号促进人白血病细胞凋亡。 Objective: To investigate the expression of SHIP1 in the patients with acute myeloid leukemia and its effect on the apoptosis of human leukemia cells. Methods: The expression of SHIP1 in the bone marrow of patients with acute myeloid leukemia was detected by Western blot. U937 cells was transfected with SHIP1 expression vector (pEGFP-SHIP1 group) and empty vector control (pEGFP group) respectively, U937 cells without transfection were used as the control group. Flow cytometry was used to detect the apoptosis of the cells, the expression of SHIP 1, Bcl-2, Bax, Akt, p-Akt were detected by western blot. Results: The expression of SHIP 1 in the bone marrow of patients with acute myeloid leukemia was significantly lower than that of the normal human bone marrow SHIP1 (P〈0. 01). The SHIP1 and Bax expressions as well as the apoptotic rate ofpEGFP-SHIP1 group were significantly higher than those of the control group(P〈0.01), while the Bcl-2 and p-Akt expressions were significantly lower than those in the control group(P〈0.01). Conclusions: SHIP1 expression was down regulated in the bone marrow of patients with acute myeloid leukemia. SHIP1 could promote the apoptosis of human leukemia cells via Akt signaling pathway.
出处 《现代生物医学进展》 CAS 2017年第23期4441-4445,共5页 Progress in Modern Biomedicine
基金 河南省医学科技攻关计划项目(122102310502)
关键词 急性髓细胞白血病 SHIP1 人白血病细胞 凋亡 Acute myeloid leukemia SHIP 1 Human leukemia cells Apoptosis
  • 相关文献

参考文献1

二级参考文献15

  • 1Huntzinger E,Izaurralde E.Gene silencing by microRNAs:contributions of translational repression and mRNA decay.Nat Rev Genet,2011,12(2):99-110.
  • 2Whitman SP,Maharry K,Radmacher MD,et al.FLT3 internal tandem duplication associates with adverse outcome and gene and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia:a cancer and leukemia group B study.Blood,2010,116(18):3622-3626.
  • 3Marcucci G,Maharry KS,Metzeler KH,et al.Clinical role of microRNAs in cytogenetically normal acute myeloid leukemia:miR-155upregulation independently identifies high-risk patients.J Clin Oncol,2013,31(17):2086-2093.
  • 4O'Connell RM,Rao DS,Chaudhuri AA,et al.Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloprolierative disorder.J Exp Med,2008,205(3):585-594.
  • 5Danen-van Oorschot AA,Kuipers JE,Arentsen-Peters S,et al.Differentially expressed miRNAs in cytogenetic and molecular subtypes of pediatric acute myeloid leukemia.Pediatr Blood Cancer,2011,58(5):715-721.
  • 6Yamanaka Y,Tagawa H,Takahashi N,et al.Aberrant overexpression of microRNAs activate AKT signaling via downregulation of tumor suppressors in natural killer cell lymphoma/leukemia.Blood,2009,114(15):3265-3275.
  • 7Poltronieri P,D'Urso PI,Mez2011a V,et al.Potential of anti-cancer therapy based on anti-miR-155 oligonucleotides in glioma and brain tumours.Chem Biol Drug Des,2013,81(1):79-84.
  • 8Sun Y,Wang M,Lin G,et al.Serum microRNA-155 as a potential biomarker to track disease in breast cancer.PLo S One,2012,7(10):e47003.
  • 9Pedersen IM,Otero D,Kao E,et al.Onco-miR-155 targets SHIP1to promote TNFa-dependent growth of B cell lymphomas.EMBO Mol Med,2009,1(5):288-295.
  • 10O'Connell RM,Chaudhuri AA,Rao DS,et al.Inositol phosphatase SHIP1 is a primary target of miR-155.Proc Natl Acad Sci USA,2009,106(17):7113-7118.

共引文献3

同被引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部